Friends of the Fund

After the birth of my first daughter 14 years ago, I discovered running as a way to care for myself while navigating the joys and demands of motherhood.

Running was never about chasing medals, personal records, or crossing finish lines first. It became something much deeper than that—a way to honor the people I’ve lost.

In early 2023, my mom, Carol M. Byrne (CMB—just like the Research Fund’s namesake), was diagnosed with HR+/HER2- breast cancer.

I joined Team Baldwin because I wanted my miles to mean more than just crossing another finish line.

My name is Kaitlyn Trimarchi and I am running this marathon in honor of my best friend Haley, who passed away in January after a battle with metastatic breast cancer.

On May 27th, 2024, my mother told me she had been diagnosed with breast cancer back in April.

My name is Zuri Adelekan, and I will be running the 2026 TCS New York City Marathon with Team Baldwin!

Running the New York City Marathon has been at the top of my bucket list for years, but this year, it means something much deeper.

Ten months after giving birth to my son, I was diagnosed with de novo Stage IV HER2-positive, hormone receptor-positive breast cancer.